401 related articles for article (PubMed ID: 16713277)
1. Theoretical and experimental determination of dosimetric characteristics for ADVANTAGE Pd-103 brachytherapy source.
Meigooni AS; Dini SA; Awan SB; Dou K; Koona RA
Appl Radiat Isot; 2006 Aug; 64(8):881-7. PubMed ID: 16713277
[TBL] [Abstract][Full Text] [Related]
2. Determination of dosimetric characteristics of OptiSeed(TM) a plastic brachytherapy (103)Pd source.
Wang Z; Hertel NE
Appl Radiat Isot; 2005 Sep; 63(3):311-21. PubMed ID: 15964196
[TBL] [Abstract][Full Text] [Related]
3. Monte Carlo and experimental characterization of the first AMIRS 103Pd brachytherapy source.
Raisali G; Ghonchehnazi MG; Shokrani P; Sadeghi M
Appl Radiat Isot; 2008 Dec; 66(12):1856-60. PubMed ID: 18657981
[TBL] [Abstract][Full Text] [Related]
4. Experimental measurements and Monte Carlo calculations of dosimetric parameters of the IRA1-103Pd brachytherapy source.
Sadeghi M; Hosseini SH; Raisali G
Appl Radiat Isot; 2008 Oct; 66(10):1431-7. PubMed ID: 18387806
[TBL] [Abstract][Full Text] [Related]
5. Theoretical and experimental determination of dosimetric characteristics for brachyseed Pd-103, model Pd-1, source.
Meigooni AS; Zhang H; Perry C; Dini SA; Koona RA
Appl Radiat Isot; 2003 May; 58(5):533-41. PubMed ID: 12735969
[TBL] [Abstract][Full Text] [Related]
6. Dosimetric characteristics of the new RadioCoil 103Pd wire line source for use in permanent brachytherapy implants.
Meigooni AS; Zhang H; Clark JR; Rachabatthula V; Koona RA
Med Phys; 2004 Nov; 31(11):3095-105. PubMed ID: 15587663
[TBL] [Abstract][Full Text] [Related]
7. Experimental and theoretical determination of dosimetric characteristics of IsoAid ADVANTAGE 125I brachytherapy source.
Meigooni AS; Hayes JL; Zhang H; Sowards K
Med Phys; 2002 Sep; 29(9):2152-8. PubMed ID: 12349937
[TBL] [Abstract][Full Text] [Related]
8. Study of the IsoAid ADVANTAGE (125)I brachytherapy source dosimetric parameters using Monte Carlo simulation.
Sadeghi M; Hamed Hosseini S
Appl Radiat Isot; 2010 Jan; 68(1):211-3. PubMed ID: 19762248
[TBL] [Abstract][Full Text] [Related]
9. Monte Carlo dosimetric characterization of the IsoAid ADVANTAGE 103Pd brachytherapy source.
Sowards KT
J Appl Clin Med Phys; 2007 Mar; 8(2):18-25. PubMed ID: 17592461
[TBL] [Abstract][Full Text] [Related]
10. A Monte Carlo evaluation of the dosimetric characteristics of the EchoSeed Model 6733 (125)I brachytherapy source.
Sowards KT; Meigooni AS
Brachytherapy; 2002; 1(4):227-32. PubMed ID: 15062171
[TBL] [Abstract][Full Text] [Related]
11. Brachytherapy dosimetry parameters calculated for a new 103Pd source.
Rivard MJ; Melhus CS; Kirk BL
Med Phys; 2004 Sep; 31(9):2466-70. PubMed ID: 15487726
[TBL] [Abstract][Full Text] [Related]
12. Dosimetric characteristics of the InterSource103 palladium brachytherapy source.
Meigooni AS; Sowards K; Soldano M
Med Phys; 2000 May; 27(5):1093-100. PubMed ID: 10841414
[TBL] [Abstract][Full Text] [Related]
13. Monte Carlo calculations and experimental measurements of dosimetric parameters of the IRA-103Pd brachytherapy source.
Sadeghi M; Raisali G; Hosseini SH; Shavar A
Med Phys; 2008 Apr; 35(4):1288-94. PubMed ID: 18491522
[TBL] [Abstract][Full Text] [Related]
14. Dosimetric characteristics of the bests double-wall 103Pd brachytherapy source.
Meigooni AS; Bharucha Z; Yoe-Sein M; Sowards K
Med Phys; 2001 Dec; 28(12):2568-75. PubMed ID: 11797962
[TBL] [Abstract][Full Text] [Related]
15. Calculated microdosimetric characteristics of 125I and 103Pd brachytherapy seeds at different depths in water.
Wuu CS; Chen J
Radiat Prot Dosimetry; 2006; 122(1-4):506-8. PubMed ID: 17189276
[TBL] [Abstract][Full Text] [Related]
16. A photon spectrometric dose-rate constant determination for the Advantage Pd-103 brachytherapy source.
Chen ZJ; Bongiorni P; Nath R
Med Phys; 2010 Feb; 37(2):672-4. PubMed ID: 20229876
[TBL] [Abstract][Full Text] [Related]
17. Dosimetric study of a new polymer encapsulated palladium-103 seed.
Bernard S; Vynckier S
Phys Med Biol; 2005 Apr; 50(7):1493-504. PubMed ID: 15798339
[TBL] [Abstract][Full Text] [Related]
18. Dosimetric characterization of an 192Ir brachytherapy source with the Monte Carlo code PENELOPE.
Casado FJ; García-Pareja S; Cenizo E; Mateo B; Bodineau C; Galán P
Phys Med; 2010; 26(3):132-9. PubMed ID: 20034828
[TBL] [Abstract][Full Text] [Related]
19. Dosimetric characteristics of the Pharma Seed model BT-125-I source.
Popescu CC; Wise J; Sowards K; Meigooni AS; Ibbott GS
Med Phys; 2000 Sep; 27(9):2174-81. PubMed ID: 11011748
[TBL] [Abstract][Full Text] [Related]
20. Dosimetric characterization of radioactive sources employed in prostate cancer therapy.
Zilio VO; Joneja OP; Popowski Y; Chawla R
Brachytherapy; 2004; 3(4):201-14. PubMed ID: 15607152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]